Related Experiment Video
Updated: Feb 8, 2026

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Lung Transplantation with Controlled Donation after Circulatory Death Donors
Ilhan Inci1, Sven Hillinger1, Didier Schneiter1
1Department of Thoracic Surgery, Zurich University Hospital, Switzerland.
Insights
Lung transplants using donation after circulatory death (DCD) donors show comparable long-term survival rates to those from donation after brain death (DBD) donors, offering a safe solution to donor shortages.
Area of Science:
- Thoracic surgery
- Transplantation immunology
- Organ donation
Background:
- Donor shortage is a critical issue in lung transplantation.
- Donation after circulatory death (DCD) offers a potential solution to increase organ availability.
Purpose of the Study:
- To evaluate the long-term outcomes of lung transplantation (LTx) using DCD donors.
- To compare the survival rates of LTx recipients from DCD versus donation after brain death (DBD) donors.
Main Methods:
- Retrospective analysis of consecutive DCD (Maastricht Category III) and DBD donor lung transplants.
- Comparison of survival rates between DCD and DBD groups as the primary outcome measure.
Main Results:
- No 90-day mortality observed in the DCD group.
- 1- and 3-year survival rates were 100% and 80% for DCD donors versus 85% and 69% for DBD donors (p=0.4).
- Primary graft dysfunction (PGD) grade 3 occurred in three recipients; chronic lung allograft dysfunction (CLAD) caused death in two cases.
Conclusions:
- Lung transplantation from DCD donors demonstrates comparable long-term outcomes to those from DBD donors.
- The utilization of DCD donors is a safe and effective strategy to address the shortage of donor lungs.
Purpose:
Utilization of donation after circulatory death (DCD) donors has the potential to decrease donor shortage in lung transplantation (LTx). This study reviews the long-term outcome of LTx from DCD donors.
Methods:
We included all consecutive DCD (Maastricht Category III) and all donations after brain death (DBD) donor lung transplants at our Center performed between January 2012 and February 2017. Data were analyzed comparing the two groups in regard of survival after LTx as primary outcome.
Results:
Median withdrawal to cardiac arrest time was 17 min (interquartile range [IQR]: 11.5-20.5). Median cardiac arrest to cold perfusion was 32 min (IQR: 24.5-36.5). Primary graft dysfunction (PGD) grade 3 at T72 occurred in three recipients. Chronic lung allograft dysfunction (CLAD) led to death in two cases. In DCD group, there was no 90-day mortality. In DCD, group 1- and 3-year survival rates were 100% and 80%. In DBD group, 1- and 3-year survival rates were 85% and 69% (p = 0.4).
Conclusions:
Our report confirmed the comparable outcome from DCD donors compared with DBD donors. Utility of DCD donors is a safe option to overcome donor shortage.
More Related Videos
Related Concept Videos
Anatomy of the Circulatory System
Lung Capacity
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Control System Problem
When forming a closed-loop system, issues can arise if the poles cross into the unstable region, leading to potential...

